Literature DB >> 10385563

Extraovarian granulosa cell tumor.

J B Robinson1, D D Im, L Logan, W P McGuire, N B Rosenshein.   

Abstract

OBJECTIVE: The aim of this study was to report a case of extraovarian granulosa cell tumor and to describe its relevance to the histologic origin of granulosa cell tumors and to clinical practice.
METHODS: The clinical course and histopathology of the case were reviewed, and a literature search for other reported cases was performed.
RESULTS: A 67-year-old woman presented with postmenopausal bleeding and a pelvic mass. Laparotomy revealed a 16-cm mass arising from the right pelvic sidewall, filling the pelvis, and involving the bladder and rectosigmoid colon. Both ovaries appeared normal and were separate from the mass. Pathologic examination revealed granulosa cell tumor. A literature search revealed no recently reported cases of extraovarian granulosa cell tumor.
CONCLUSIONS: Granulosa cell tumors can arise in locations other than the ovary and may be derived from the mesenchyme of the genital ridge. Women who have undergone oophorectomy may have the potential to develop granulosa cell tumors. Copyright 1999 Academic Press.

Entities:  

Mesh:

Year:  1999        PMID: 10385563     DOI: 10.1006/gyno.1999.5375

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Extraovarian granulosa cell tumor of mesentery: a case report.

Authors:  Manjiri R Naniwadekar; N J Patil
Journal:  Patholog Res Int       Date:  2010-03-04

2.  Recurrent granulosa cell tumor of the retroperitoneum during the COVID-19 Pandemic.

Authors:  Yasmin Abedin; Upasana Madan; Deena Graham; Mira C Hellmann
Journal:  Gynecol Oncol Rep       Date:  2022-03-16

3.  Primary mesenteric sertoli-leydig cell tumor: a case report and review of the literature.

Authors:  Amel Trabelsi; Soumaya Ben Abdelkarim; Mohamed Hadfi; Ridha Fatnaci; Wided Stita; Badreddine Sriha; Sadok Korbi
Journal:  J Oncol       Date:  2008-10-30       Impact factor: 4.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.